153 related articles for article (PubMed ID: 7176659)
1. The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction.
Adlercreutz H; Brown J; Collins W; Goebelsman U; Kellie A; Campbell H; Spieler J; Braissand G
J Steroid Biochem; 1982 Dec; 17(6):695-702. PubMed ID: 7176659
[TBL] [Abstract][Full Text] [Related]
2. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
4. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
5. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
6. A possible method for the detection of ovulation and the determination of the duration of the fertile period.
Baker TS; Jennison K; Kellie AE
J Steroid Biochem; 1980 Jan; 12():411-5. PubMed ID: 7421226
[TBL] [Abstract][Full Text] [Related]
7. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle.
Blackwell LF; Brown JB; Cooke D
Steroids; 1998 Jan; 63(1):5-13. PubMed ID: 9437789
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
9. Temporal relationships between indices of the fertile period.
Fertil Steril; 1983 May; 39(5):647-55. PubMed ID: 6840308
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
11. Symptothermal and hormonal markers of potential fertility in climacteric women.
Flynn AM; James P; Collins WP; Royston P
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
[TBL] [Abstract][Full Text] [Related]
12. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
14. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide.
Branch CM; Collins PO; Kilpatrick MJ; Collins WP
Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791
[TBL] [Abstract][Full Text] [Related]
15. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
[TBL] [Abstract][Full Text] [Related]
16. The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year.
Landgren BM; Jonsson B; Cekan SZ
Contraception; 1995 Apr; 51(4):255-60. PubMed ID: 7796592
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical tests of potential fertility.
Collins WP
Biochem Soc Trans; 1992 Feb; 20(1):234-7. PubMed ID: 1633952
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
19. Determination of ovarian function using first morning urine steroid assays.
Denari JH; Farinati Z; Casas PR; Oliva A
Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function and the return of potential fertility in lactating women.
Mills AM; O'Reilly CP; Collins WP
Int J Fertil Menopausal Stud; 1994; 39(1):32-8. PubMed ID: 8167678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
